Volume 4, Issue10
Clinical-laboratory peculiarities of the course of infiltrative tuberculosis combined with chronic bronchitis in complex treatment using glucosaminyl muramyl pentapeptide
Author: Melnyk OP, Ostrovskyi MM
Abstract: Tuberculosis – is an infectious disease that affects not only antisocial population, but can affect any person. Whereas, it is transmitted by airborne droplets through coughing, sneezing or communication with the patient with active TB of the lungs, people with impaired immunity arising after such diseases as pneumonia, bronchitis, peptic ulcer, diabetes mellitus, can fall ill. According to WHO data this diagnosis is made approximately to 1.000 people in Europe, and the morbidity indexes show that it will be difficult to overcome TB on this continent during the coming 85 years. We have examined 40 patients with infiltrative tuberculosis combined with chronic bronchitis, of which 22 patients have taken immunomodulator together with anti-mycobacterial medicines, and 18 patients – only standard treatment scheme. The results of the study show the expediency of administration of the immunomodulator together with anti-TB medicines.
Download Full Article: Click Here
Support Us
If you are interested in supporting our work and would like to contribute, you are welcome to mail me at jpbr.anil@gmail.com or at info@thepharmajournal.com it will be a great help and will surely be appreciated.
